Zerbaxa Approved for Hospital-Acquired Bacterial Pneumonia

TUESDAY, June 11, 2019 -- Zerbaxa (ceftolozane and tazobactam) has been approved for a new indication to treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) in patients aged 18 years and older, the...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news